Profilo
Priyanka Shah is currently working as the VP of Investor Relations & Communications at Kinnate Biopharma, Inc. Previously, she worked as the Head of Media Relations at Mirati Therapeutics, Inc.
Posizioni attive di Priyanka Shah
Società | Posizione | Inizio |
---|---|---|
KINNATE BIOPHARMA INC. | Investor Relations Contact | - |
Precedenti posizioni note di Priyanka Shah
Società | Posizione | Fine |
---|---|---|
MIRATI THERAPEUTICS | Public Communications Contact | 01/04/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Kinnate Biopharma, Inc.
Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Priyanka Shah